In our studied cohort of PC patients, the highest mutation frequency has BRCA2 (5%), BRCA1 (2.2%), HOXB13 (1.6%) and PMS2 (1%), and all others have below 1% mutations. Here, BRCA2 is linked to pachyonychia congenita.